EVALUATION OF ANTI-INFLAMMATORY AND OTHER BIOLOGICAL ACTIVITIES OF FLAVONOID BASED CREAM FORMULATION FOR TOPICAL APPLICATION USING IN VITRO MODEL
HTML Full TextEVALUATION OF ANTI-INFLAMMATORY AND OTHER BIOLOGICAL ACTIVITIES OF FLAVONOID BASED CREAM FORMULATION FOR TOPICAL APPLICATION USING IN VITRO MODEL
Shahlla Imam 1, Najma Shaheen 2, Farhana Tasleem 2, Iqbal Azhar 2 and Zafar Alam Mahmood *2
Institute of Pharmaceutical Sciences 1, Jinnah Sindh Medical University Karachi - Pakistan.
Department of Pharmacognosy 2, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi - Pakistan.
ABSTRACT: Biologically active compounds identified as flavonoids, glycosides, alkaloids, saponins, terpenoids and polyphenolics from plant extracts possess health promoting properties. The use of natural antioxidants in the treatment of various skin diseases has gained utmost importance in recent years. Therefore, present study was designed and conducted with the aim to evaluate the anti-inflammatory activity of cream formulation containing fruit extracts of Musa acuminata, Psidium guajava and Pyrus communis using in vitro model. Fruit of M. acuminata, P. guajava and P. communis were extracted by cold percolation, comprising of ethanol, methanol and distilled water. The cream formulation and the reference drug (Diclofenac sodium) of varying concentrations were incubated with fresh egg albumin under specified experimental conditions and subjected to determination of absorbance and viscosity to assess the in vitro anti-inflammatory activity. Linear regression analysis was used to calculate IC50 value. The results revealed that cream formulation and diclofenac sodium inhibited protein denaturation in a dose-dependent manner. The IC50 value of cream formulation 1254.13±16.91µg/ml and diclofenac sodium was recorded as 845.82±16.94µg/ml at correlation coefficient value (r) of 0.900 and 0.983 respectively. The study gives an idea that the fruits extract can be used as a lead compound for designing a potent topical anti-inflammatory drug.
Keywords: |
In vitro, Anti-inflammatory, Antioxidant, Diclofenac sodium, Flavonoids, Formulation, Protein denaturation
INTRODUCTION: Fruits represent a large natural source of valuable compounds that may serve as lead for the identification and development of new bioactive compounds. In modern era, there has been an increasing interest in diets comprising of fruits and vegetables due to their important role in the prevention of various degenerative disorders of skin.
This preventive effect is primarily reported owing to the presence of bioactive compounds such as polyphenols, resveratrol, flavonoids, carotenoids, proanthocyanins, tannins and Vitamins 1. These polyphenolic compounds are widely disseminated in nature as active constituents of herbs, shrubs, fruits, cereals, vegetables and plant derived products such as tea, coffee and instant energy juices. Due to established biological effects these are attractive substances for many areas of human life. Plants, herbs and their preparations and secondary metabolites have been used since the prehistoric time to modern medicine. Accordingly ethanomedicine have constituted one of the strong bases of treatment for healthcare all over the world.
Fruits are the wellspring of various phytonutrients such as Vitamins, polyphenols, tannins, flavonoids and carotenoids. It is well established that fruits have many health related beneficial effect thus, consumption of such fruits will have a positive effect on health and will contribute in decreasing the mortality rate of cardiovascular and other degenerative diseases. Therefore, fruits extracts are mostly added to the cosmetic preparations and skin care products. It gives a natural divine fragrance and color and may help to treat dermatitis, acne, eczema and other skin problems 2, 3.
Flavonoids are the largest group of plant pigments, which are consumed with food as well as in the form of dietary supplements or herbal products. Epidemiological studies showed that flavonoids possess a number of pharmacological activities, such as anti-microbial, antioxidant, anti-allergic, anti-inflammatory, anti-cancer, anti-diabetic, cardio-protective, hepato-protective and detoxi-fication activities 4 - 6. As fruit extracts are usually rich in flavonoids, therefore, have great applications in cosmetology, phytopharmaceuticals and food supplements. These applications are well developed and documented mostly due to their anti-oxidant property. In addition, also reported to play an important role in topically applied products such as in anti-aging, anti-acne and in sunscreen formulations 2. Thus, manufacturers are striving to develop a formulation containing phyto-nutrients and bioactive natural compounds and their use is continually fueling the cosmaceuticals and personal care industries 7.
Based on this scientific information, present work is aimed and designed to screen the extracts from fruits to develop a stable topical cream formulation. In present study various biological activities such as antioxidant, antimicrobial and anti-inflammatory activity of cream formulation was determined through in-vitro tests.
MATERIALS AND METHODS:
Drugs and Chemicals: All chemicals and solvents used were of analytical grade and purchased locally.
Instruments: Double beam Shimadzu UV-Vis spectrophotometer equipped with 1cm quartz cell, pH meter (Systronics), centrifuge machine (HERMLE Labortechnik GmbH, Germany), Vacuum rotary evaporator (BUCHI, Switzerland), weighing balance (Sartorius) and pH meter (Systronics), incubator were the instruments used in the study.
Plant Materials: The ripe fruit samples Musa acuminata Colla (Banana), Psidium guajava L. (Guava) and Pyrus communis L. (Pear) were purchased from a local market of Karachi, Pakistan, as per availability during the season.
Plant Extraction: The fruit pulp of banana, peeled fruit pulps of guava and pear were macerated separately in a mixture of solvent system comprising of ethanol and methanol (35%) and distilled water (30%) for 15 days at room temperature. The contents were filtered and concentrated under reduced pressure using rotary evaporator. Thick, viscous hydro-alcoholic extracts obtained from each fruit was kept into an air tight amber colored glass bottle.
Identification Test for Flavonoids: The hydro-alcoholic fruit extracts were subjected to qualitative analysis using an alkaline reagent test. 5ml of hydro-alcoholic fruit extracts were treated separately with 2 ml of sodium hydroxide solution. An intense yellow color precipitates was formed which turned into colorless, on addition of a few drops of diluted hydrochloric acid indicated the presence of flavonoids 8.
Determination of Total Flavonoid Contents (TFC): TFC was determined using aluminium chloride (AlCl3) colorimetric method. The total flavonoid contents were expressed in term of quercetin equivalent (QE) µg/g using the standard calibration curve (y= 0.0009x + 0.001, r2= 0.9189).
Cream Formulation and its Preparation: Cream formulation was prepared using ingredients shown in Table 1. The oil phase of cream was prepared by heating the ingredients (cetostearyl alcohol, stearic acid, cetomacrogol-1000, lanolin and glycerin) at 75 °C ± 2 with constant stirring using hot plate. While, for the preparation of aqueous phase purified water was heated separately in 2000 ml capacity beaker at 80 °C ± 2. To this methyl and propyl parabens were dissolved with occasional stirring and temperature was brought to 75 °C ± 2. The two phases (oil and aqueous) were mixed together with vigorous stirring for about 1-2 minutes. Finally, the fruit extracts were added with constant stirring till a thick cream was formed. The temperature was further reduced to around 45 °C using cold-water bath and stirring was discontinued. The cream was stored in wide mouth air tight amber colored glass container and kept at room temperature.
TABLE 1: COMPOSITION OF CREAM FORMULATION
Ingredients | Uses | Components
(% w/w) |
Cetostearyl alcohol | Emulsifier | 35 |
Stearic acid | Emollient, Co-emulsifier | 40 |
Cetomacrogol-1000 | Emulsifier | 9 |
Lanolin | Emollient | 50 |
Glycerin | Humectant | 156.6 |
Methyl paraben | Preservative | 4 |
Propyl paraben | Preservative | 0.4 |
hydro-alcoholic fruit extract of M. acuminata, P. guajava and P. communis | Active ingredient | 10 |
Distilled water | Vehicle | 695 |
Total weight | - | 1000 |
Antioxidant Activity: The in vitro anti-oxidant activity was determined by reducing power assay 9. Ascorbic acid was used as a standard. The percentage of reduction was calculated from the following formula:
Percentage of reduction power = [1- (1- As/Ac)] x 100
Where, Ac is the absorbance of standard at maximum concentration tested and As is the absorbance of sample.
Anti-microbial Activity: The anti-microbial activity was conducted against standard ATCC cultures which include: Staphylococcus aureus (ATCC - 6538), Bacillus subtilis (ATCC - 6633), Pseudomonas aeruginosa (ATCC-27853), Escherichia coli (ATCC-14169) and Candida albicans (ATCC - 10231). The activity was executed using varying concentration ranges 100 - 400 µg per disc of test sample respectively. Cefotaxime (CFX), commercial antibiotic disc was employed as a positive control against S. aureus, B. subtilis, E. coli and Ceftriaxone (CTZ) was used against P. aeruginosa as a positive control for anti-bacterial screening, while, for anti-fungal screening Miconazole nitrate (MN) was used as a positive control against C. albicans.
Cream formulation (500 mg) was weighed accurately and transferred in a 25 ml volumetric flask. It was dissolved with ethanol using a vortex mixer. Accurately 5 µl, 10 µl, 15 µl and 20 µl solutions were applied to adequately label sterile discs to make a concentration of 100, 200, 300 and 400µg/disc respectively. To achieve a concentra- tion of 1x106 CFU/ml, approximately 1 ml of 1x 108 CFU/ml culture was poured into 100 ml media (SDA) and (TSA). 25 ml of media was then poured in each petri dish and allowed to solidify before use. Each prepared disc of cream infused with different concentrations, along with a standard selected antibiotic was placed gently on the agar surface. These plates were kept at 4 °C for 24 hours to allow maximum diffusion of test and reference materials. After this, the seeded plates were incubated at 37 °C for 24-72 hours to observe the zone of inhibition of anti-bacterial and anti-fungal activity 10.
Anti-inflammatory Activity: In vitro anti-inflammatory activity was determined by inhibition of protein (egg albumin) denaturation method 11, 12.
Control Solution (50 ml): Phosphate buffer saline (28ml) of pH 6.4 was transferred to freshly prepared egg albumin (2ml) and distilled water (20ml) was added to this, to prepared control solution.
Standard Solution (50 ml): Phosphate buffer saline (28ml) of pH 6.4 was transferred to freshly prepared egg albumin (2ml) and (20ml) solution of diclofenac sodium of different concentration ranges from 10 - 2000 µg/ml was added to this, to prepared standard solution.
Test Solution (50 ml): Phosphate buffer saline (28 ml) of pH 6.4 was transferred to freshly prepared egg albumin (2 ml) and (20ml) solution of cream formulation of different concentration ranges from 10 - 2000 µg/ml was added to this, to prepared test solution.
All the solutions were incubated at 37 ± 2 °C for 15 minutes and it was then heated at 70 °C on a water bath for 5 minutes. The solutions were allowed to cool at room temperature. The absorbance was then measured using UV-Visible spectrophotometer at 660 nm using vehicle as blank. The percentage inhibition of protein denaturation was calculated from the control using below under formula:
Percentage of inhibition = 100 x (Abs control -Abstest /Abs control)
Whereas, Abs is the absorbance.
The viscosity of solutions was determined by using Ostwald viscometer. The IC50 value represents the concentration (µg/ml) of test sample, required for 50% inhibition.
Statistical Analysis: Statistical Program for Social Sciences (SPSS Corporation, Chicago, IL), version 20.0 software was used for the analysis. The experimental data was presented as mean ± SD and one way (ANOVA) followed by Tukey’s post- hoc test was used for multiple comparison between treatment groups (p < 0.05). Linear regression analysis was used to calculate the IC50 value. Regression analysis was used to determine correlation between the ferric reducing power and protein denaturation.
RESULTS AND DISCUSSION:
Total Flavonoid Content and Anti-oxidant Activity: The TFC of hydro-alcoholic fruit extract of M. acuminata was found to be 8.04 ± 3.4, P. guajava 11.37 ± 3.57, P. communis 11.37 ± 3.4 QE µg/g (Table 2). Flavonoids don’t seem to be readily detectable therefore, aluminium chloride (AlCl3) was used as complexing reagent. The method is based upon the formation of stable complex between AlCl3 and keto and hydroxyl groups of flavones and flavonoids. It is one of the most frequently used methods applied to the flavonoid content determination in various plants13. Plant secondary metabolites like phenolic acids, flavonoids, carotenoids, proanthocyanins and certain Vitamin such as Vitamin C and E contributing for the anti-oxidant activity, depicting a therapeutic potential. However, concentration of these phytochemicals are varying due to genetic makeup of the species, geographical region, climatic and soil conditions, cultivation time, pre and post-harvesting technique, ripening stage, processing and storage conditions 14, 15.
It is well established that the reducing capacity of bioactive compounds is related to the anti-oxidant activity. The reducing power of cream formulation was found to be 73.48 ± 1.30 ascorbic acid equivalents (AES) µg/g. The anti-oxidants present in the cream formulation caused their reduction of Fe/ ferricyanide complex to the ferrous form and thus, proved the reducing power. The anti-oxidant activity could be correlated with the polyphenolic components present in the cream.
TABLE 2: TOTAL FLAVONOIDS CONTENT OF FRUITS EXTRACT
Concentration (µg/ml) | Musa acuminata | Psidium guajava | Pyrus communis |
25 | 4.33 | 8.78 | 7.67 |
50 | 8.78 | 9.89 | 12.11 |
100 | 11 | 15.44 | 14.33 |
Mean | 8.04 ± 3.4 | 11.37 ± 3.57 | 11.37 ± 3.4 |
Anti-microbial Activity: Results shown in Table 3 revealed that all the test organisms have some degree of dose - related sensitivity and thus the zone of inhibition increases with the increase in concentration of cream. Better sensitivity results have been observed against Gram- positive organisms compared Gram - negative organisms. The growth of B. subtilis and S. aureus, both were noted to be inhibited against all the four concentrations (100, 200, 300 and 400µg) of cream used, with the maximum zone of inhibition of 9.83 and 9.50mm respectively against 400µg. The standard drug Cefotaxime produced a zone of 15.0 mm with a concentration of 30µg.
In case of Gram- negative organisms (E. coli and P. aeruginosa) smaller zone of inhibitions were recorded at 200, 300 and 400µg, while no zone of inhibition was noted at 100 µg concentration. The maximum zone of inhibition of 7.86 mm and 7.03mm were recorded against E. coli and Pseudomonas aeruginosa with 400µg. The standard drug Cefotaxime produced a zone of 18.0 mm with a concentration of 30µg against E. coli, while Ceftriaxone produced a zone of 20mm against P. aeruginosa with 30µg. The antifungal effect on C. albicans was noted batter than antibacterial effect. A zone of inhibition of 13.50 mm was recorded against 400µg concentration, while Miconazole nitrate produced 22mm zone of inhibition with 40µg concentration.
The active contents of the cream, Musa acuminata, Psidium guajava and Pyrus communis have been studied individually and reported to possess anti-microbial properties16-20. The overall anti-microbial activity of these fruits can be ascribed with the presence of flavonoids and phenolic substances present as bioactive constituent, while the mechanism of their anti-microbial activity have been proposed due to inhibition of nucleic acid synthesis, cytoplasmic membrane function, or energy metabolism 21-24.
The anti-microbial effect of cream formulation was effective however; it can be assumed that even a low degree of anti-microbial effect of the cream formulation will be helpful in the eradication of common microorganisms with its regular application, especially the Gram - positive bacteria and some fungi associated with skin problems.
TABLE 3: IN VITRO ANTI-MICROBIAL ACTIVITY OF CREAM FORMULATION
Name of microorganisms / ATCC Number |
Zone Inhibition (mm) | ||||||
Disc concentration
(µg) of Cream |
Standard Antibiotic Disc | ||||||
400 | 300 | 200 | 100 | (CFX* / CTX* / MN**) | |||
Antibacterial screening | B. subtilis
ATCC6633 |
Plate 1 | 10.0 | 9.0 | 7.0 | 6.0 | 15.0 mm |
Plate 2 | 9.5 | 8.0 | 6.3 | 5.9 | 15.0 mm | ||
Plate 3 | 10.0 | 8.0 | 7.2 | 6.2 | 15.0 mm | ||
Average zone of inhibition. | 9.83
mm |
8.33
mm |
6.83
mm |
6.03
mm |
15.0 mm | ||
S. aureus
ATCC6538 |
Plate 1 | 9.5 | 9.5 | 7.5 | 6.8 | 12.0 mm | |
Plate 2 | 10.0 | 9.0 | 8.0 | 6.5 | 12.0 mm | ||
Plate 3 | 9.0 | 9.0 | 8.3 | 7.0 | 12.0 mm | ||
Average zone of inhibition | 9.5
mm |
9.16
mm |
7.83
mm |
6.76
mm |
12.0 mm | ||
E. coli
ATCC14169 |
Plate 1 | 8.0 | 6.7 | 5.2 | R | 18.0 mm | |
Plate 2 | 7.8 | 6.2 | 4.8 | R | 18.0 mm | ||
Plate 3 | 7.8 | 6.0 | 5.0 | R | 18.0 mm | ||
Average zone of inhibition | 7.86
mm |
6.30
mm |
5.0
mm |
R | 18.0 mm | ||
P. aeruginosa
ATCC 27853 |
Plate 1 | 7.3 | 7.0 | 5.0 | R | 20 mm | |
Plate 2 | 7.0 | 6.5 | 4.8 | R | 20 mm | ||
Plate 3 | 6.8 | 6.5 | 4.5 | R | 20 mm | ||
Average zone of inhibition | 7.03
mm |
6.66
mm |
4.76
mm |
R | 20 mm | ||
Antifungal screening | C. albicans
ATCC 10231 |
Plate 1 | 13.2 | 9.8 | 7.6 | 6.5 | 22.0 mm |
Plate 2 | 13.5 | 10.0 | 7.5 | 7.0 | 22.0 mm | ||
Plate 3 | 13.8 | 9.5 | 8.0 | 6.8 | 22.0 mm | ||
Average zone of inhibition | 13.5 | 9.76 | 7.70 | 6.76
|
22.0 mm |
* Cefotaxime (CFX) = 30μg/disc, Ceftriaxone (CTX) = 30μg/disc, ** Miconazole nitrate disc MN (40μg/disc).
Anti-inflammatory Activity: Ethical issues are the main problem related to animal’s model in experimental research 25. Therefore, the protein denaturation bioassay was selected for in vitro assessment of anti- inflammatory activity of cream formulation based on their flavonoid content. It is simple and convenient method to evaluate the anti-inflammatory activity. Present findings revealed that cream formulation and diclofenac sodium (reference drug) were exhibited a concentration-dependent inhibition of protein denaturation ranges from 10-2000 μg/ml.
The % age inhibition of protein denaturation of diclofenac sodium was observed within the range of 26.3 - 74.8 % and cream formulation was 11 - 58.5 % throughout the concentration range of 10 to 2000μg/ml. Inhibitory concentration (IC50) value of cream was recorded as 1254.13 ± 16.91 µg/ml and diclofenac sodium 845.82 ± 16.94 µg/ml at correlation coefficient value (r) of 0.900 and 0.983 respectively (Table 4). From the IC50 values it becomes evident that cream formulation was active as diclofenac sodium. A Tukey’s post - hoc test revealed that inhibition of protein denaturation was statistically significant when cream formulation and diclofenac sodium was compared to control. Therefore, from the results of the present study it can be concluded that cream formulation possessed anti-inflammatory activity. The anti-denaturation effect was further supported by the change in viscosities. It has been mentioned in various reports that the viscosities of protein solutions increase on denaturation 12, 26. The viscosity of protein solutions are expected to be dependent on the concentration, shape, size, molecular weight, flexibility, intermolecular interactions, the degree of hydration and charge of the proteins. The viscosity can also be influenced by external factors such as temperature, pH and ionic strength and % age of solvent used.
TABLE 4: ANTI-INFLAMMATORY ACTIVITY BY PROTEIN DENATURATION
Concentration
µg/ml |
Diclofenac sodium | Cream formulation | ||
% Inhibition | Viscosity (cps) | % Inhibition | Viscosity (cps) | |
Control | - | 1.33 | - | 1.33 |
10 | 26.3 ± 0.15 | 0.96 | 11 ± 0.30 | 0.62 |
50 | 26.8 ± 0.20 | 0.99 | 18.5±0.55 | 0.70 |
100 | 31.6 ± 0.21 | 1.01 | 24±0.10 | 0.77 |
200 | 36.7 ± 0.50 | 1.05 | 30.6±0.6 | 0.81 |
400 | 40.9 ± 0.15 | 1.08 | 35.3±0.06 | 0.88 |
800 | 52.3 ± 0.32 | 1.10 | 48.5±0.21 | 0.97 |
1000 | 56.9 ± 0.15 | 1.12 | 51.7±0.1 | 0.98 |
2000 | 74.8 ± 0.20 | 1.14 | 58.8±0.06 | 1.02 |
IC50 | 845.82 ± 16.94 µg/ml | 1254.13 ± 16.91µg/ml | ||
Coefficient value (r) | 0.983 | 0.900 |
Values were expressed as mean ± SD (n=3).
Linear regression analysis was used to calculate IC50 value. One way analysis of variance (ANOVA) followed by Tukey’s post- hoc test was used as the test of significance. The mean difference is significant at the 0.05 level. Denatured protein solution had a higher viscosity due to its larger molecule size. However, the viscosities were found to decrease with a concomitant decrease in concentration of test sample and reference drug as well. While, the viscosities of the cream formulation of all concentrations were always found less than that of control. The effect of concentration of test agent on the viscosity behaviour of denatured protein dispersion requires further studies 27, 28. It was also noted that the reducing power anti-oxidant activity correlated strongly with anti-inflammatory activity as shown in Fig. 1 (y = 0.0821x + 70.907, R² = 0.903).
In the present study, the in vitro anti-inflammatory activity of cream formulation can be attributed to its polyphenol contents. The flavonoids, tannins and saponins have the ability to bind cations and able to protect the protein membrane from denaturation. Therefore, polyphenolic compounds could be the possible reason for anti-denaturation property. Several flavonoids have been found to possess anti-inflammatory activity by inhibiting cycloxygenase-2 (COX2), tyrosine kinase and neutrophil degranulation. It has been reported that anti-oxidant activities of flavonoids can also help in establishing the anti-inflammatory activity 25. Several anti-necrotic, digestive, neuroprotective hepato-protective and anti-inflammatory, drugs have recently been shown to have anti-oxidant and/or radical scavenging mechanism as part of their activity 29, 30.
FIG. 1: CORRELATION BETWEEN FERRIC REDUCING POWER ANTIOXIDANT ACTIVITY AND PERCENTAGE INHIBITION OF PROTEIN DENATURATION
The in vitro results appear as interesting and promising and may be effective as potential sources of topical anti-inflammatory drugs. It is proposed that anti-inflammatory effect need to be further assessed in other experimental models in pursuit of newer phyto-therapeutic against inflammatory diseases and to determine the mechanisms behind its anti-inflammatory actions.
CONCLUSION: The study provided reasonable data to conclude that seasonal fruits possess antioxidant property which is capable of protecting the skin from harmful effect of various physico-chemical factors. Despite great advancement within the field of synthetic drugs, plants still have their own unique place, having no side effects. Thus, a method should be made to find out the usefulness of plants against inflammation so as to use them as natural anti-inflammatory agents with low toxicity and higher therapeutic value. Present findings provide scientific evidence to support traditional medicinal uses and indicate a promising potential for the development of an anti-inflammatory agent from plant.
ACKNOWLEDGMENT: We would like to thank Dr. Shaista Perveen, Department of Chemistry, University of Karachi and Syed Ghazanfar Hussain, Department of Chemistry, NED University of Engineering and Technology, Karachi - Pakistan for providing necessary laboratory facilities to conduct the study.
CONFLICT OF INTEREST: All the authors declared that there is no conflict of interest regarding the publication of this paper.
REFERENCES:
- Zlotek U, Szymanowska U, Baraniak B and Karas M: Antioxidant activity of polyphenols of adzuki bean (Vigna angularis) germinated in abiotic stress conditions. Acta Scientiarum Polonorum Technologia 2015; 14(1): 55-62.
- Ribeiro AS, Estanqueiro M, Oliveira MB and Lobo JMS: Main benefits and applicability of plant extracts in skin care products. Cosmetics 2015; 2: 48-65.
- Reddy MP, Gobinath M, Rao KM, Venugopalaiah P and Reena N: A review on importance of herbal drugs in cosmetics. International Journal of Advances in Pharmacy and Nanotechnology 2011; 1(3): 121-139.
- Solanki I, Parihar P, Mansuri ML and Parihar MS: Flavonoid - based therapies in the early management of neuro degenerative diseases. Advances in Nutrition 2015; 6: 64-72.
- Georgie V, Ananga A and Tsolova V: Recent advances and uses of grape flavonoids as nutraceuticals. Nutrients 2014; 6: 391- 415.
- Raina GS: Significant emergent role of flavonoids as valuable nutraceuticals: Systemic Review. International Journal of Pharmacotherapy 2013; 3(2): 44-51.
- Chermahini SH, Abdul Majid FA and Sarmidi MR: Cosmaceuticals value of herbal extracts as natural ingredients and novel technologies in anti-aging. Journal of Medicinal Plants Research 2011; 5(14): 3074 -3077.
- Yadav RNS and Agarwala M: Phytochemical analysis of some medicinal plants. Journal of Phytology 2011; 3(12): 10-14.
- Imam S, Azhar I, Perveen S, Hussain SG and Mahmood ZA: Studies on in vitro antioxidant activity and total flavonoid contents of a cream formulation to correlate its anti-aging effect. World Journal of Pharmaceutical Research 2015; 4(1): 1646-1655.
- Sultan RA, Mahmood SBZ, Azhar I, Ahmed SW and Mahmood ZA: Biological activities assessment of Centell aasiatica (Linn.) Journal of Herbs, Spices and Medicinal Plants 2014; 20: 319-327.
- Sangeetha G and Vidhya R: In vitro anti-inflammatory activity of different parts of Pedalium murex (L.) International Journal of Herbal Medicine 2016; 4(3): 31-36.
- Gautam RK, Sharma S and Sharma K: Comparative evaluation of anti-arthritic activity of Pongamia pinnata (Linn.) Pierre and Punica granatum An in-vitro study. International Journal of Pharmacy and Pharmaceutical Sciences 2013; 5(4): 721-724.
- Pekal A and Pyrzynska K: Evaluation of aluminium complexation reaction for flavonoid content assay. Food Analytical Methods 2014; 7: 1776-1782.
- Pereira A and Maraschin M: Banana (Musa spp) from peel to pulp: Ethnopharmacology, source of bioactive compounds and its relevance for human health. Journal of Ethnopharmacology 2015; 160: 149-163.
- Gull J, Sultana B, Ashrafuzzaman M, Anwar F, Naseer R, Ashraf M: Variation in antioxidant attributes at three ripening stages of guava (Psidium guajava) fruit from different geographical regions of Pakistan. Molecules 2012; 17: 3165-3180.
- Sharma K, Pasricha V, Satpathy G, Gupta RK: Evaluation of phytochemical and antioxidant activity of raw Pyrus communis (L.), an underexploited fruit. Journal of Pharmacognosy and Phytochemistry 2015; 3(5): 46-50.
- Sroka Z, Żbikowska B, Janicki K, Franiczek R, Krzyżanowska B and Drys A: Antimicrobial and antiradical activity of extracts obtained from leaves of three species of the genus Pyrus. Microbial Drug Resistance 2014; 20(4): 337-343.
- Jain, Bhuiyan MH, Hossain KR and Bachar SC: Antibacterial and antioxidant activities of local seeded banana fruits. African Journal of Pharmacy and Pharmacology 2011; 5(11); 1398-1403.
- Malaviya A and Mishra N: Antimicrobial activity of tropical fruits. Biological Forum - An International Journal 2011; 3(1): 1-4.
- Pandey A and Shweta: Antibacterial properties of Psidium guajava leaves, fruits and stems against various pathogens. International Journal of Pharmaceutical Research and Development 2012; 3(11): 15-24.
- Kuponiyi E and Ibibia T: A Review on antimicrobial and other beneficial effects of flavonoids. International Journal of Pharmaceutical Sciences Review and Research 2013; 21(1): 20-33.
- Kumar S and Pandey AK: Chemistry and biological activities of flavonoids: An overview. The Scientific World Journal. vol 2013, Article ID 162750, 16 pages, 2013. doi:10.1155/2013/162750.
- Agrawal AD: Pharmacologicalactivities of flavonoids: A review. International Journal of Pharmaceutical Sciences and Nanotechnology 2011; 4(2): 1394-1398.
- Hendra R, Ahmad S, Sukari A, Shukor MY and Oskoueian E: Flavonoid analysis and antimicrobial activity of various parts of Phaleria macrocarpa (Scheff.) Boerl fruit. International Journal of Molecular Science 2011; 12: 3422-3431.
- Shallangwa GA, Musa H and Nyaga GT: In-vitro evaluation of ethanolic extracts of Zingiber officinale, Sygzium aromaticum and their 1:1 extracts blend on protein denaturation during acute inflammation. Journal of Progressive Research in Chemistry 2015; 1(1): 1-8.
- Vennila V and Anitha R: In vitro evaluation of anti-arthritic activity in different solvent extracts from Cuscuta reflexa. World Journal of Pharmacy and Pharmaceutical Sciences 2015; 4(4): 1340-1350.
- Prasad SB, Yashwant and Aeri V: In vitro anti-inflammatory activity of Raupya (Silver) Bhasma. Journal of Chemical and Pharmaceutical Research 2013; 5: 194-197.
- Chandra S, Chatterjee P, Dey P, Bhattacharya S: Evaluation of in vitro anti-inflammatory activity of coffee against the denaturation of protein. Asian Pacific Journal of Tropical Biomedicine 2012; 2(1): S178-S180.
- Chaudhary N and Tripathi S: A review on multipurpose plant: Psidium guajava. International Journal of Pharmacognosy and Phytochemical Research 2014; 6(1): 118-121.
- Sulaiman M, Tijani HI, Abubakar BM, Haruna S, Hindatu Y, Mohammed JN and Idris Abdulrahman I: An overview of natural plant antioxidants: analysis and evaluation. Advances in Biochemistry 2013; 1(4): 64-72.
How to cite this article:
Imam S, Shaheen N, Tasleem F, Azhar I and Mahmood ZA: Evaluation of anti-inflammatory and other biological activities of flavonoid based cream formulation for topical application using in vitro model. Int J Pharm Sci Res 2017; 8(10): 4388-95.doi: 10.13040/IJPSR.0975-8232.8(10).4388-95.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
42
4388-4395
437
1399
English
IJPSR
S. Imam, N. Shaheen, F. Tasleem, I. Azhar and Z. A. Mahmood *
Member Board of Studies and Co-Supervisor, Department of Pharmacognosy, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi- Pakistan.
zamahmood@hotmail.com
20 February, 2017
22 April, 2017
27 May, 2017
10.13040/IJPSR.0975-8232.8(10).4388-95
01 October, 2017